There are no published guidelines regarding the optimal management of pasireotide-induced hyperglycemia in patients with acromegaly 22 , but the most currently recommended treatment is metformin, followed by dipeptidyl peptidase-4 (DPP-4) inhibitors, GLP-1 analogs, and then insulin 22,23,24
The first is retatrutide
Correction Perhaps the most crucial finding from the clinical research is the importance of timing interventions appropriately
Gradual discontinuation may reduce rebound effects compared to abrupt cessation
Does semaglutide with glycine need to be refrigerated differently
Nutritional priorities to support GLP -1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society